Involvement of S1P1receptor pathway in angiogenic effects of a novel adenosine‐like nucleic acid analogCOA‐Cl in cultured human vascular endothelial cells
Open Access
- 6 August 2014
- journal article
- research article
- Published by Wiley in Pharmacology Research & Perspectives
- Vol. 2 (5) , e00068
Abstract
COA‐Cl (2Cl‐C.OXT‐A) is a recently developed adenosine‐like nucleic acid analog that promotes angiogenesis via the mitogen‐activated protein (MAP) kinasesERK1/2. Endothelial S1P1receptor plays indispensable roles in developmental angiogenesis. In this study, we examined the functions of S1P1inCOA‐Cl‐induced angiogenic responses. Antagonists for S1P1, W146, andVPC23019, substantially but still partly inhibited the effects ofCOA‐Cl with regard toERK1/2 activation and tube formation in cultured human umbilical vein endothelial cells (HUVEC). Antagonists for adenosine A1receptor and purinergic P2Y1receptor were without effect. Genetic knockdown of S1P1with siRNA, but not that of S1P3, attenuatedCOA‐Cl‐elicitedERK1/2 responses. The signaling properties ofCOA‐Cl showed significant similarities to those of sphingosine 1‐phosphate, an endogenous S1P1ligand, in that both induced responses sensitive to pertussis toxin (Gαi/o inhibitor), 1,2‐bis(2‐aminophenoxy)ethane‐N,N,N',N'‐tetraacetic acid tetrakis (acetoxymethyl ester) (BAPTA‐AM), (calcium chelator), andPP2 (c‐Src tyrosine kinase inhibitor).COA‐Cl elevated intracellular Ca2+concentration and induced tyrosine phosphorylation of p130Cas, a substrate of c‐Src, inHUVEC.COA‐Cl displaced [3H]S1P in a radioligand‐binding competition assay in chem‐1 cells overexpressing S1P1. However,COA‐Cl activatedERK1/2 inCHO‐K1 cells that lack functional S1P1receptor, suggesting the presence of additional yet‐to‐be‐definedCOA‐Cl target in these cells. The results thus suggest the major contribution of S1P1in the angiogenic effects ofCOA‐Cl. However, other mechanism such as that seen inCHO‐K1 cells may also be partly involved. Collectively, these findings may lead to refinement of the design of this nucleic acid analog and ultimately to development of small molecule‐based therapeutic angiogenesis.Keywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology of Japan (25461132, 24591654)
- SENSHIN Medical Research Foundation
- Kagawa University Faculty of Medicine
This publication has 35 references indexed in Scilit:
- Essential Role of Class II Phosphatidylinositol-3-kinase-C2α in Sphingosine 1-Phosphate Receptor-1-mediated Signaling and Migration in Endothelial CellsJournal of Biological Chemistry, 2013
- The Sphingosine-1-Phosphate Receptor S1PR1 Restricts Sprouting Angiogenesis by Regulating the Interplay between VE-Cadherin and VEGFR2Developmental Cell, 2012
- Regulation of Mammalian Physiology, Development, and Disease by the Sphingosine 1-Phosphate and Lysophosphatidic Acid ReceptorsChemical Reviews, 2011
- Therapeutic angiogenesis using naked DNA expressing two isoforms of the hepatocyte growth factor in a porcine acute myocardial infarction model☆European Journal of Cardio-Thoracic Surgery, 2008
- Rac1 Modulates Sphingosine 1-Phosphate-mediated Activation of Phosphoinositide 3-Kinase/Akt Signaling Pathways in Vascular Endothelial CellsJournal of Biological Chemistry, 2006
- G-protein-coupled receptor S1P1 acts within endothelial cells to regulate vascular maturationBlood, 2003
- Sphingosine 1‐phosphate effect on endothelial cell PAF synthesis: Role in cellular migrationJournal of Cellular Biochemistry, 2003
- Sphingosine 1-Phosphate and Isoform-specific Activation of Phosphoinositide 3-Kinase βJournal of Biological Chemistry, 2001
- Sphingosine 1-Phosphate and Activation of Endothelial Nitric-oxide SynthaseJournal of Biological Chemistry, 2001
- Differential Pharmacological Properties and Signal Transduction of the Sphingosine 1-Phosphate Receptors EDG-1, EDG-3, and EDG-5Journal of Biological Chemistry, 1999